CLINICAL_TRIALS
research
· 2025-06-19
Clinical Trial Update: Improving the Perception of Stress and Mutuality in Caregivers (MI-DEAR Study) of Migraine Patients With Depressive Symptoms Treated With Fremanezumab: A Study to Evaluate Whether Fremanezumab Reduces the Impact on Caregivers and Increases Couple Reciprocity
Summary
A recruiting clinical trial (MI-DEAR) studies whether fremanezumab for migraine with depressive symptoms reduces caregiver burden and improves couple reciprocit…
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Fondazione Policlinico Universitario Campus Bio-Medico | Conditions: Migraine | Status: RECRUITING